Kay K et al. demonstrated that cisplatin-based treatment upon MM cell lines favored the selection of a side population with increased replicative potential and high expression levels of stemness-related genes, including OCT4, NOTCH1 and BMI1 [44]. This evidence concerns the gene POU5F1 and Miyoshi myopathy.